Is Amrize AG (AMRZ) a risky stock?
As of July 25, 2026, Clavix grades Amrize AG (AMRZ) B- for risk, a composite score of 70 out of 100 on an A+ to F scale, which puts AMRZ in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 25, 2026. Clavix regrades every trading day.
AMRZ price, last 3 months
AMRZ's daily closes over the past three months. Clavix reads risk from the fundamentals and news behind the price, not the line itself.
The five risk dimensions behind AMRZ's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how AMRZ scores on each, as of July 25, 2026.
What's moving AMRZ's risk right now
Company-specific signals Clavix flags behind AMRZ's current grade, drawn from recent news and filings as of July 25, 2026.
The 4.4% price target cut signals slightly tempered near-term valuation expectations from Oppenheimer, though the maintained outperform rating indicates the firm still views Amriz…
The additional buying signals continued institutional confidence in Amrize Ltd, though the 13F filing only reflects a single quarter's activity and does not indicate longer-term c…
This modernization strengthens Amrize's competitive positioning in Eastern Canada by expanding production capacity and reducing its carbon footprint, potentially unlocking governm…
Recent AMRZ news
The latest headlines Clavix ingested for Amrize AG, newest first. These feed the news-sentiment dimension of AMRZ's grade.
-
Oppenheimer lowered its price target on Amrize (NYSE:AMRZ) from $68.00 to $65.00 while maintaining an 'outperform' rating in a report issued on Tuesday.
-
Amrize has agreed to acquire Rapid Redi-Mix LLC, a fast-growing concrete producer in the Dallas-Fort Worth metro area with modern batch plants and a mixer fleet, strengthening its presence in the Texas market.
What a B- grade means
On the Clavix A+ to F scale, AMRZ's composite of 70 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell AMRZ or any security. Grades are risk indicators, not predictions of return. Data may be delayed.